Profiles, interviews and career journeys of pathologists, researchers and innovators shaping the future of diagnostic medicine worldwide.
Bridging computational imaging and clinical pathology, Prof. Madabhushi has spent two decades developing AI algorithms that extract quantitative features from digitized tissue slides to predict treatment response and patient outcomes. His work on computational stroma analysis in breast cancer has been validated across multiple international cohorts.
Emory University, Atlanta · Computational Pathology & AI · 280+ Publications · h-index 72
Read Full ProfileProfiles of the world's most influential pathologists shaping clinical practice, research and education across every continent and subspecialty.
Former Vice-Principal of the University of Edinburgh and a towering figure in surgical pathology, Sir David led the transformation of Scotland's pathology services into one of Europe's most advanced digital diagnostic networks. His research in vascular pathology and atherosclerosis has been cited over 12,000 times, and he chaired the Scottish Government's review of laboratory medicine that reshaped service delivery across NHS Scotland. Knighted for services to medicine and higher education, he remains an influential voice in pathology workforce planning and digital infrastructure strategy.
A driving force behind precision oncology in the Gulf Cooperation Council region, Prof. Al-Khatib directs the Molecular Diagnostics Division at King Faisal Specialist Hospital and Research Centre in Riyadh. She established the first comprehensive next-generation sequencing programme for solid tumours in the Kingdom and has been instrumental in building collaborative research networks between GCC institutions and leading European cancer centres. Her work on EGFR and ALK testing protocols has become the standard across Saudi Arabia's national oncology network, and she has mentored over 40 molecular pathology fellows from across the Middle East.
Head of the Division of Neuropathology at the University of Tokyo Hospital, Prof. Takahashi is one of the principal architects of the WHO Classification of Tumours of the Central Nervous System, Fifth Edition. His laboratory pioneered the integration of methylation profiling with histopathological assessment for brain tumour subtyping, a methodology now adopted by neuropathology centres worldwide. He has published over 260 peer-reviewed papers on glioma biology and molecular classification and received the Japanese Society of Neuropathology's highest honour, the Gruenberg Award, in 2023.
Professor of Cytopathology at the University of São Paulo and director of the Brazilian National Cervical Screening Quality Assurance Programme, Prof. Santos-Silva has spent 25 years improving cervical cancer prevention across Latin America. Her landmark multi-centre trial comparing liquid-based cytology with conventional Pap testing in low-resource settings informed screening policy across Brazil, Colombia and Peru. She chairs the International Academy of Cytology's Education Committee and has trained a generation of cytopathologists through her renowned fellowship programme, which has graduated over 120 specialists from 14 countries.
Professor of Hematopathology at Charité — Universitätsmedizin Berlin and a key contributor to the WHO Classification of Haematolymphoid Tumours. Prof. Weber's research group has been at the forefront of integrating genomic data into lymphoma classification, with their work on the molecular subtypes of diffuse large B-cell lymphoma reshaping treatment stratification in clinical trials across Europe. He serves on the editorial boards of four international journals, has authored 290 peer-reviewed publications, and received the European Hematology Association's Jean Bernard Lifetime Achievement Award in 2024 for his contributions to diagnostic hematopathology.
Professor and Head of the Department of Pathology at the All India Institute of Medical Sciences (AIIMS), New Delhi, Prof. Sharma is widely regarded as the leading authority on gastrointestinal pathology in South Asia. Her research on tropical sprue, intestinal tuberculosis and coeliac disease in the Indian subcontinent has defined diagnostic criteria used by pathologists across the region. She led the AIIMS-ICMR collaborative study on inflammatory bowel disease patterns in India, which demonstrated significant epidemiological differences from Western populations. She has authored three widely used textbooks on GI pathology and published 245 peer-reviewed papers.
Chair of Dermatopathology at the Mayo Clinic in Rochester, Minnesota, Prof. Mitchell is an internationally recognised authority on melanocytic lesion diagnosis and melanoma prognostication. Her laboratory developed the gene expression profiling panel now used across 200 dermatopathology practices in North America to differentiate ambiguous melanocytic tumours. She led the AJCC Melanoma Staging Committee's subgroup on sentinel lymph node pathology reporting and has been awarded the American Society of Dermatopathology's Gruenberg Award, the Arthur C. Allen Award, and the Gruenberg Lectureship for contributions to the field. She has published 195 peer-reviewed papers and trained 38 dermatopathology fellows.
Director of Research at the Institut Pasteur de Tunis and Professor of Medical Microbiology at the University of Tunis El Manar, Prof. Ben Salah has dedicated his career to the pathology and epidemiology of infectious diseases in North Africa. His clinical trials on cutaneous leishmaniasis treatment protocols have been adopted by the World Health Organization as first-line guidance for the Mediterranean region. He established the Pasteur Institute's Biobank of Infectious Disease Specimens, a resource now used by researchers across three continents, and serves as President of the African Society for Laboratory Medicine's Pathology Division. He has published 175 papers and mentored 52 doctoral students.
Professor of Anatomical Pathology at the University of Melbourne and Head of Breast Pathology at the Peter MacCallum Cancer Centre, Prof. Chen is a global leader in biomarker research for breast cancer. Her laboratory identified novel predictive biomarkers for response to immunotherapy in triple-negative breast cancer, now being validated in three international Phase III clinical trials. She co-chairs the International Society of Breast Pathology's Biomarker Standardisation Working Group and has been instrumental in harmonising HER2 testing guidelines across the Asia-Pacific region. She has published 220 peer-reviewed papers, holds four patents, and was awarded the Pathological Society of Great Britain and Ireland's Goudie Medal in 2025.
Professor of Forensic Pathology and Medicolegal Medicine at the University of Lagos College of Medicine and Chief Forensic Pathologist for Lagos State, Prof. Adeyemi is the most prominent forensic pathology voice on the African continent. He established Nigeria's first accredited forensic pathology training programme and has been instrumental in modernising medicolegal death investigation standards across West Africa. His research on drowning pathology in tropical environments and his advocacy for standardised autopsy protocols in resource-limited settings have influenced policy in twelve African nations. He serves as President of the African Academy of Forensic Sciences and has published 135 peer-reviewed papers and three forensic pathology textbooks.
Head of the Department of Pathology at Hôpital Ambroise Paré in Boulogne-Billancourt and Professor of Pathology at Université Paris-Saclay, Prof. Émile is one of the world's foremost authorities on gastrointestinal stromal tumours. His research defined the molecular classification of GIST resistance mutations and established the pathological criteria for predicting imatinib response that are now incorporated into ESMO clinical practice guidelines. He led the French national GIST registry, the largest in Europe with over 6,000 cases, and his group's work on KIT and PDGFRA mutation profiling has been cited more than 8,500 times. He was awarded the French National Order of Merit for contributions to cancer diagnostics.
Professor of Renal Pathology at the University of Cape Town and Director of the South African Renal Biopsy Registry, Prof. Wood has transformed the understanding of kidney disease patterns across sub-Saharan Africa. Her epidemiological studies on HIV-associated nephropathy in the South African population defined the histological spectrum of the disease and guided treatment protocols adopted by the Southern African HIV Clinicians Society. She established the continent's first electron microscopy unit dedicated to renal biopsy diagnosis in a public hospital and trained over 60 renal pathology fellows from 18 African countries through her fellowship programme. She has published 165 papers and received the International Society of Nephrology's Roscoe R. Robinson Award.
Pioneer in computational pathology and founder of the Tissue Image Analytics Centre at the University of Warwick. His group developed TIAToolbox, one of the most widely used open-source tools for computational pathology, and his research in graph neural networks for tumour microenvironment analysis has set new benchmarks in the field. Prof. Rajpoot's work on automated grading of colorectal cancer has been validated in multi-centre NHS trials and is being evaluated for clinical deployment across multiple trusts.
Leading researcher in deep learning for histopathology image analysis at Radboud University Medical Center. His group has been instrumental in validating AI algorithms for clinical diagnostic use in breast and prostate pathology, and his contributions to the CAMELYON grand challenges helped establish the gold-standard benchmarks for metastasis detection in lymph nodes. Prof. van der Laak serves on the Digital Pathology Association's AI Task Force and advises the European Commission on regulatory frameworks for AI in diagnostics.
One of the earliest advocates for digital pathology adoption in clinical practice. Prof. Yagi led the digital transformation of pathology services at Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center, developing the operational frameworks and validation protocols that have since been adopted as industry standards. Her practical work on scanner selection, image quality assurance and LIMS integration has guided dozens of laboratories through their digital transitions across North America, Europe and Asia.
Mid-career pathologists and researchers making transformative contributions to the field and poised to shape the next decade of diagnostic medicine.
Assistant Professor of Computational Pathology at Karolinska Institutet, Stockholm. Dr. El-Khoury developed a self-supervised learning framework for histopathological image analysis that reduces annotation requirements by 90%, enabling AI deployment in laboratories without large annotated datasets. Her work has been published in Nature Medicine and she holds two pending patents on federated learning architectures for multi-site pathology data. Originally trained in clinical pathology at the American University of Beirut, she completed a postdoctoral fellowship at ETH Zurich before joining Karolinska at the age of 34.
Head of Molecular Pathology at Sultan Qaboos University Hospital, Muscat, and the youngest department head in the institution's history. Dr. Al-Balushi established Oman's first clinical whole-genome sequencing programme for hereditary cancer syndromes and built a variant interpretation pipeline tailored to Middle Eastern population genetics. He co-leads the GCC Genomic Medicine Consortium's Pathology Working Group and was named among the Lancet's 30 Under 40 leaders in laboratory medicine in 2025. He has published 38 peer-reviewed papers and secured $4.2 million in research funding.
Consultant Paediatric Pathologist at Great Ormond Street Hospital, London, and Honorary Senior Lecturer at University College London. Dr. Okafor's research on Wilms tumour biology in African-descent populations identified novel prognostic biomarkers now being validated in a multi-centre international trial. She leads the Royal College of Pathologists' Diversity in Pathology initiative and founded the annual African Paediatric Pathology Symposium, which has connected over 300 paediatric pathologists across 22 countries. She was awarded the Pathological Society of Great Britain and Ireland's Young Investigator Prize in 2024.
Associate Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Director of the Digital Pathology Innovation Lab. Dr. Zhang developed the first FDA-cleared AI algorithm for automated Ki-67 scoring in breast cancer and led the validation study that demonstrated equivalence to expert pathologist consensus. His research on spatial transcriptomics integration with digital pathology imaging has opened new avenues for understanding tumour heterogeneity. He holds six patents and his work has attracted over $8 million in NIH and industry funding.
Senior Pathologist at the Institut Pasteur de Dakar and WHO Collaborating Centre for Arboviral Diseases. Dr. Diallo established rapid molecular diagnostic protocols for haemorrhagic fevers that reduced laboratory turnaround time from 72 hours to under 6 hours during the 2024 Marburg outbreak in West Africa. She developed a point-of-care histopathology staining kit for field hospitals that has been deployed in four Medecins Sans Frontieres missions. Named a WHO Expert Advisory Panel member at age 37, she has published 52 papers and trained 28 laboratory scientists across francophone Africa.
Associate Professor of Uropathology at Heidelberg University Hospital and coordinator of the European Uropathology Network's AI validation programme. Dr. Petrova's research on artificial intelligence-assisted Gleason grading demonstrated that AI-pathologist collaboration improves inter-observer concordance by 35% compared to either alone, a finding that has influenced clinical implementation strategies across 14 European centres. She developed the first standardised digital competency curriculum for uropathology trainees, now adopted by the European Society of Pathology's training committee. She has published 56 papers and received the German Cancer Society's Young Investigator Award.
Leaders from the companies building the platforms, scanners, AI algorithms and infrastructure that are transforming pathology from analogue to digital, from subjective to quantitative.
Chief Executive Officer of Paige, the company behind the first FDA-approved AI product for clinical pathology diagnosis. Under his leadership, Paige secured CE-IVD marking and FDA clearance for AI-assisted prostate cancer detection and has expanded its foundation model programme to cover 17 cancer types. Dr. Grady previously held senior positions at Siemens Healthineers and HeartFlow, bringing two decades of experience in translating medical imaging research into regulated clinical products. He holds 76 patents and has published extensively on graph-theoretic methods in medical image analysis.
Co-founder and Chief Executive Officer of PathAI, which has built one of the largest AI-powered pathology platforms for drug development and clinical diagnostics. A pathologist and computational scientist by training, Dr. Beck completed his residency at Brigham and Women's Hospital and postdoctoral research at Harvard Medical School before founding PathAI in 2016. The company's platform has been used in over 150 clinical trials by 15 of the world's 20 largest pharmaceutical companies, and its AISight diagnostic tool has received CE marking for breast cancer biomarker quantification. Dr. Beck has published over 40 peer-reviewed papers on computational pathology.
Global Head of Digital Pathology at Roche Diagnostics, overseeing the development and commercial deployment of the Navify Digital Pathology platform and uPath enterprise software suite. Dr. Schalck led the integration of AI-assisted image analysis into Roche's tissue diagnostics workflow, creating an end-to-end digital ecosystem from tissue processing through automated scoring for PD-L1, HER2 and Ki-67 companion diagnostics. Under his direction, Roche has installed digital pathology solutions in over 400 laboratories worldwide and established partnerships with academic institutions for algorithm validation. He holds a PhD in biomedical engineering from ETH Zurich.
Chief Technology Officer of the Medical Systems Division at Hamamatsu Photonics, the Japanese manufacturer behind the NanoZoomer series of whole-slide scanners used in pathology laboratories and research institutions across 65 countries. Dr. Yoshida led the engineering team that developed the NanoZoomer S360MD, the first whole-slide scanner to receive regulatory clearance for primary clinical diagnosis in both the United States and Japan. His team's work on high-speed line-scanning optics and fluorescence imaging has produced 28 patents and enabled scanning speeds that make digital-first pathology workflows economically viable for high-volume laboratories.
General Manager of Philips Digital Pathology Solutions, responsible for the IntelliSite Pathology Suite that was the first digital pathology system cleared by the FDA for primary diagnosis in the United States. Dr. Waterfall has overseen deployments at some of the world's largest pathology networks, including the NHS's Northern Pathology Imaging Cooperative and the Dutch national digital pathology infrastructure programme. His strategic vision for an open ecosystem approach — enabling third-party AI algorithms to integrate with Philips' imaging platform — has positioned the company as a preferred partner for academic medical centres building computational pathology programmes.
The most prestigious awards and honours recognising outstanding contributions to pathology, laboratory medicine and diagnostic science worldwide.
The highest honour bestowed by the United States and Canadian Academy of Pathology, recognising a pathologist whose career contributions have fundamentally advanced the discipline. Past recipients include pioneers in molecular diagnostics, surgical pathology classification and digital pathology adoption.
Presented by the American Society of Dermatopathology for outstanding contributions to dermatopathology research. The award honours investigators whose work has significantly improved the diagnosis and classification of cutaneous diseases, with particular emphasis on translational research that bridges laboratory findings and clinical practice.
The most prestigious lectureship in European pathology, awarded by the European Society of Pathology to a distinguished pathologist whose research and teaching have had a transformative international impact. The lecture is delivered at the European Congress of Pathology before an audience of over 3,000 delegates from 80 countries.
Awarded by the Pathological Society of Great Britain and Ireland for distinguished contributions to experimental pathology and laboratory science. Named after the legendary Glasgow pathologist Robert Goudie, the medal recognises individuals whose work has advanced both the science and the practice of pathology in clinical and research settings.
Established by the Digital Pathology Association in 2020, this award recognises the individual, team or organisation that has made the most significant contribution to advancing the adoption of digital pathology and computational approaches in clinical practice. Nominations are reviewed by an international panel of digital pathology leaders and industry experts.
The International Academy of Pathology's premier award for teaching excellence, honouring pathologists and educators who have made sustained and innovative contributions to pathology education. Past recipients have been recognised for developing open-access digital teaching collections, pioneering virtual microscopy curricula and creating international fellowship networks that have trained hundreds of pathologists in low-resource settings.
In-depth conversation with Prof. Thomas Fuchs, Mount Sinai Health System, on the clinical deployment of AI in pathology, regulatory challenges, and preparing the pathology workforce for digital transformation.
Prof. Nadia Al-Suwaidi discusses the strategic decisions, procurement challenges, and training requirements behind Saudi Arabia's national digital pathology infrastructure initiative.
Dr. Mariam El-Sayed shares her journey from clinical pathology training in Egypt to establishing a computational pathology research group at Karolinska Institutet, including practical advice for international career transitions.
Prof. Jakob Nikolas Kather discusses the promises and limitations of large-scale vision foundation models for histopathology, and the validation evidence needed before clinical adoption.
Prof. Catherine Wood discusses how a network of electron microscopy units and telepathology connections is expanding access to renal biopsy diagnosis across sub-Saharan Africa, the challenges of training pathologists in resource-limited settings, and why kidney disease in African populations requires its own classification frameworks.
Prof. Oluwaseun Adeyemi reflects on three decades of advocacy for forensic pathology standards in West Africa, the political and institutional challenges of modernising death investigation, and the emerging generation of African forensic scientists he has mentored through the Lagos programme.
Celebrating the contributions of women pathologists, researchers and laboratory leaders advancing the field worldwide.
Know a pathologist, researcher, educator or laboratory leader making a significant impact? Nominate them for a feature profile or interview on Global Pathology Publications.
Submit Nomination